Anagrelide and the CALR mutation allele burden in essential thrombocythemia
Saved in:
| Date: | 2018 |
|---|---|
| Main Authors: | Atkinson, E., Bakri, M., Hayat, A., Langabeer, S.E. |
| Format: | Article |
| Language: | English |
| Published: |
Інститут експериментальної патології, онкології і радіобіології ім. Р.Є. Кавецького НАН України
2018
|
| Series: | Experimental Oncology |
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/145568 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Anagrelide and the CALR mutation allele burden in essential thrombocythemia / E. Atkinson, M. Bakri, A. Hayat, S.E. Langabeer // Experimental Oncology. — 2018 — Т. 40, № 2. — С. 152–153. — Бібліогр.: 9 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
-
Implication of protocadherin-PC in the progression of the advanced prostate cancer
by: Giannakopoulos, X., et al.
Published: (2007) -
Visual support of optimal decisions in spatial networks
by: Dodonov, A. G., et al.
Published: (2017) -
The JAK2 V617F mutation in lung cancer: caveat emptor
by: Langabeer, S.E.
Published: (2018) -
ATYPICAL BRAF MUTATIONS IN HAIRY CELL LEUKEMIA: DIAGNOSTIC AND THERAPEUTIC CONSIDERATIONS
by: LANGABEER, S.E., et al.
Published: (2025) -
Suboptimal molecular response to tyrosine kinase inhibition associated with acquisition of a T240A ABL1 kinase domain mutation in a patient with chronic myeloid leukemia
by: Langabeer, S.E., et al.
Published: (2023)